Status:

COMPLETED

Effect of Brief Dietary Intervention on Ammonia Levels

Lead Sponsor:

Hunter Holmes Mcguire Veteran Affairs Medical Center

Conditions:

Cirrhosis

Hepatic Encephalopathy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Study the impact of differing meal contents on venous ammonia levels over time in patients with cirrhosis. Patients will be given specific meals and venous ammonia analyzed over time after those meals...

Detailed Description

Patient will be instructed to collect stool for baseline assessments. After a fast (\>4h from last meal) a venous blood sample will be drawn for analysis of baseline laboratory tests and spot venous a...

Eligibility Criteria

Inclusion

  • Cirrhosis
  • Able and willing to voluntarily complete the informed consent process
  • Available for and agree to all study procedures
  • Consistent non-vegetarian Western dietary patterns for at least a month prior to the study assessed by dietary interview

Exclusion

  • MELD score \> 23
  • Unclear diagnosis of cirrhosis
  • History of liver transplant
  • Body mass index \< 18.5 or ≥ 40 kg/m2
  • Prior transjugular intrahepatic portosystemic shunt placement
  • Treatment with systemic (e.g., oral or intravenous) antibiotic (apart from rifaximin) within 4 weeks prior to enrollment
  • For those with HE: stable dose of medications (lactulose or rifaximin) without a recent (\<1 month episode of HE)
  • Current use of valproate, corticosteroids, or cytotoxic drugs.
  • Apart from chronic liver disease, any acute or chronic medical, surgical, psychiatric, or social condition including history of cerebrovascular disease (stroke, transient ischemic attack) or dementia, that may increase the subject risk associated with study participation, compromise adherence to study procedures and requirements, confound interpretation of the results, and, in the judgment of the investigator, make the subject inappropriate for enrollment.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 20 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05376488

Start Date

May 1 2022

End Date

April 20 2023

Last Update

February 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hunter Holmes McGuire VA Medical Center

Richmond, Virginia, United States, 23249